Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Testosterone in Male Veterans With Spinal Cord Injury
NCT06130449Phase 1Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of testosterone spray in spinal cord injury (SCI) and Hypogonadism (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: Electromyographic responses up to 1 day. Started Apr 2024; status: recruiting.
02
Drugs
testosterone spray
03
Conditions
spinal cord injury (SCI)Hypogonadism
Beyond the preview
Go deeper on NCT06130449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06130449.